Ahmad Hassan, Khan Mariam, Laugle Michelle, Jackson Desmond A, Burant Christopher, Malemud Charles J, Askari Ali D, Mattar Maya, Blumenthal David E, Zidar David A, Anthony Donald D
Rheumatology Section, Louis Stokes Cleveland VA, Cleveland, OH, USA.
Department of Medicine, Division of Rheumatic Diseases, Case Western Reserve University, Cleveland, OH, USA.
Int J Rheumatol. 2018 Sep 27;2018:2476239. doi: 10.1155/2018/2476239. eCollection 2018.
Red blood cell distribution width (RDW) is a routine hematologic parameter that is a predictor of cardiovascular disease (CVD) events and is independent of combined traditional risk factor scoring systems. The RDW has also been associated with rheumatic disease activity. Whether RDW is associated with traditional CVD risk factors or Atherosclerotic Cardiovascular Disease (ASCVD) 10-year CVD risk score in patients with seronegative spondyloarthritis with axial or peripheral disease has not been previously determined.
We performed a retrospective, chart review study evaluating the relationship between RDW, albumin, hemoglobin, C-reactive protein (CRP), absolute lymphocyte count (ALC), and ASCVD scoring parameters [age, hypertension status, diabetes mellitus (DM) status, lipid profile, and smoking status] in a cohort of spondyloarthritis patients, taking into consideration their HLA-B27 status, race, and treatment status.
RDW was found to positively correlate with ASCVD 10-year score and age, and ASCVD score did not change over time after patients were treated for spondyloarthritis. Albumin was found to negatively correlate with ASCVD 10-year risk score. Both RDW and albumin correlated with CRP. ALC failed to correlate with ASCVD 10-year score but did show a tendency to be associated with CVD, CVD events, and cardiac conduction abnormalities.
These data indicate that further study is warranted to evaluate RDW, albumin level, and ALC as potential predictors of CVD in the spondyloarthritis patient population.
红细胞分布宽度(RDW)是一项常规血液学参数,是心血管疾病(CVD)事件的预测指标,且独立于传统综合危险因素评分系统。RDW也与风湿性疾病活动相关。此前尚未确定在患有轴向或外周疾病的血清阴性脊柱关节炎患者中,RDW是否与传统CVD危险因素或动脉粥样硬化性心血管疾病(ASCVD)10年CVD风险评分相关。
我们进行了一项回顾性图表审查研究,评估一组脊柱关节炎患者中RDW、白蛋白、血红蛋白、C反应蛋白(CRP)、绝对淋巴细胞计数(ALC)和ASCVD评分参数[年龄、高血压状态、糖尿病(DM)状态、血脂谱和吸烟状态]之间的关系,同时考虑他们的HLA - B27状态、种族和治疗状态。
发现RDW与ASCVD 10年评分和年龄呈正相关,脊柱关节炎患者接受治疗后ASCVD评分未随时间变化。发现白蛋白与ASCVD 10年风险评分呈负相关。RDW和白蛋白均与CRP相关。ALC与ASCVD 10年评分无相关性,但确实显示出与CVD、CVD事件和心脏传导异常有关的趋势。
这些数据表明,有必要进一步研究以评估RDW、白蛋白水平和ALC作为脊柱关节炎患者人群中CVD潜在预测指标的情况。